Assess Eczema Severity With Confidence

Being able to accurately assess eczema severity is a critical part of effective early peanut introduction. Use the tools below to help you evaluate eczema severity with confidence.

“Clinicians need to know that at least 95% of infants can and should be introduced to peanuts as early as age 4 to 6 months—no food allergy testing needed. It is only very small percentage of higher-risk infants diagnosed with severe eczema or an egg allergy where sIgE testing should be considered.”

Ruchi Gupta, MD, MPH
Director, Center for Food Allergy & Asthma Research (CFAAR)
Professor of Pediatrics, Northwestern University Feinberg School of Medicine & Lurie Children’s Hospital

Examples of Eczema Severity

Hover or Tap to see Images

Mild Eczema

Slight but definite erythema (pink), slight but definite induration/papulation, and/or slight but definite lichenification. No oozing or crusting.

Mild Eczema

Moderate Eczema

Clearly perceptible erythema (dull red), clearly perceptible induration/papulation, and/or clearly perceptible lichenification. Oozing and crusting may be present.

Moderate Eczema

Severe Eczema

Marked erythema (deep or bright red), marked induration/papulation, and/or marked lichenification. Disease is widespread in extent. Oozing or crusting may be present.

Severe Eczema

“Providing infant-safe peanut foods early is especially important for babies with early-onset severe eczema who are more likely to develop a food allergy.”

George du Toit, MB, BCh
Professor in Pediatric Allergy, Evelina Children’s Hospital London and King’s College London, Investigator on the LEAP Studies

How is severe eczema defined in the NIAID Addendum Guidelines for Prevention of Peanut Allergy in the United States?

“Severe eczema is defined as persistent or frequently recurring eczema with typical morphology and distribution assessed as severe by a health care provider and requiring frequent need for prescription-strength topical corticosteroids, calcineurin inhibitors, or other anti-inflammatory agents despite appropriate use of emollients”

Validated Investigator Global Assessment scale for Atopic Dermatitis

Use this simple and free-to-use Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™) tool to help you assess eczema in the clinic.